Description de l'offre
Détails de l'annonce Poste proposé : EMEA CRM ManagerEMEA CRM ManagerReports to Global Commercial Excellence LeadLocation: Remote (EMEA)The Menarini Group is present in 140 countries worldwide with over 17,500 employees. High quality therapeutics and diagnostics solutions for patients, ethics as our underlying principle, dedication to innovation and advancement, strong people centricity and environmental sustainability. These five pillars form the foundation of the Menarini Group, an Italian pharmaceutical company with nearly 135 years of history. Founded in 1886 in Naples under the name of Farmacia Internazionale, in 1915 Menarini moved to Florence where the Group’s headquarters are located still today.More recently Menarini has made a commitment to oncology, investing in a pipeline of five investigational compounds for the treatment of a variety of hematological and/or solid tumors, and through the acquisition of Stemline Therapeutics in June 2020, Menarini strengthened its oncology portfolio with the addition of both commercial and clinical-stage assets. These assets include ELZONRIS® (tagraxofusp), a targeted therapy directed to the IL-3R (CD123), approved by the U.S. Food and Drug Administration (FDA) in 2018 for the treatment of adult and pediatric patients, with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). In Europe, in January 2021 ELZONRIS® was approved by the EMA as monotherapy for the first-line treatment of adult patients with BPDCN.The acquisition of Stemline established Menarini’s presence in the US biopharmaceutical oncology market, where the Company will support further development of Stemline’s assets and will enable global expansion by leveraging its commercial infrastructure in Europe and other ex-US geographies.Menarini entered into a global license agreement with Radius Health to complete the development of Elacestrant, an oral SERD in late stage Phase 3 development for hormone receptor-positive advanced breast cancer. Following a successful phase 3 study Menarini-Stemline is preparing for commercialization of Elacestrant in US, Europe and AsiaPacAdditionally, Menarini received exclusive …